Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
Filter By
Patenting antibodies in Europe and beyond: a comparative guide to the IP5
A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read More
The UPC’s first ruling on equivalence in patent infringement
The Unified Patent Court (UPC) has issued its first decision on patent infringement by equivalence in Plant-e Knowledge B.V. &…
Read More
EPO Board of Appeal provides rare and valuable guidance on interpretation of morality clauses under European law
A recent EPO Board of Appeal (BoA) decision (T 1553/22) considered the patentability of human-animal chimeras (organisms or tissues that…
Read More
UPC tweaks EPO inventive step approach as Sanofi succeeds against Amgen
Abstract Shortly after celebrating its one-year anniversary, things look to be very much in full swing for the Unitary Patent…
Read More
2023 Patent Landscape Report: COVID-19-related vaccines and therapeutics
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….
Read More
Why the EPO’s Enlarged Board of Appeal’s decision in G2/21 will impact inventions relating to life sciences and chemistry
The European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…
Read More
Lecanemab: could the drug with modest benefits make a big difference to Alzheimer’s patients?
Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…
Read More
What happens when your cosmetic method gives rise to therapeutic effects?
There are many innovations in the cosmetic sector that can be the subject of patent applications and these may be…
Read More